In high probability scenarios with lymphocytic exudate with high ADA and compatible clinical features, empirical anti-TB therapy can be justified despite repeatedly negative microbiology, particularly when alternative diagnoses are excluded and the patient fails to respond to appropriate antibiotics. Here, ADA is linked to tuberculosis.